ARLUMERE Trademark

Trademark Overview

On Tuesday, November 3, 2020, a trademark application was filed for ARLUMERE with the United States Patent and Trademark Office. The USPTO has given the ARLUMERE trademark a serial number of 90295279. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 19, 2024. This trademark is owned by Glenmark Specialty S.A.. The ARLUMERE trademark is filed in the Pharmaceutical Products category with the following description:

Antihistamines, nasal steroids, and nasal spray preparations for treatment of respiratory disorders
arlumere

General Information

Serial Number90295279
Word MarkARLUMERE
Filing DateTuesday, November 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 18, 2021

Trademark Statements

Goods and ServicesAntihistamines, nasal steroids, and nasal spray preparations for treatment of respiratory disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlenmark Specialty S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNeuchatel CH-2000
CH
Party NameGlenmark Specialty S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLa Chaux-de-Fonds 2300
CH

Trademark Events

Event DateEvent Description
Monday, January 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 6, 2020NEW APPLICATION ENTERED
Thursday, April 8, 2021ASSIGNED TO EXAMINER
Tuesday, April 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 18, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 18, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 27, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 27, 2021SOU EXTENSION 1 FILED
Monday, December 27, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 30, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 30, 2022SOU EXTENSION 2 FILED
Thursday, June 30, 2022SOU EXTENSION 2 GRANTED
Saturday, July 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 10, 2023SOU EXTENSION 3 FILED
Thursday, January 26, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 1, 2023SOU EXTENSION 3 GRANTED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2023SOU EXTENSION 4 FILED
Thursday, June 22, 2023SOU EXTENSION 4 GRANTED
Saturday, June 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2023SOU EXTENSION 5 FILED
Monday, December 18, 2023SOU EXTENSION 5 GRANTED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, August 19, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

arlumere nasal respiratory disorders treatment spray steroids antihistamines preparations